China Pulse logo

Biogen secures robust deal with TJ Biopharma in massive $850 million China rights acquisition


Source: ChinaSourcingNews.com ChinaSourcingNews.com
Key Topics in this News Article:
News Snapshot:

In a revolutionary move, Biogen has struck a monumental deal for the China rights to an immune disease drug, partnering with TJ Biopharma. The agreement could reach a staggering $850….. Subscribe for Full Access! Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years! Subscribe! Share this Data

  • This field is for validation purposes and should be left unchanged.

  • Newsletter to Your Inbox

    China intelligence delivered each week!

  • This field is hidden when viewing the form

News Timeline:
Track the development of this news story across the Internet.

January 27, 2026

Fangzhou Secures HK$150 Million in Share Placement for AI-Driven Healthcare Innovation


Source: ChinaMoneyNetwork.com ChinaMoneyNetwork.com

January 3, 2026

US President Blocks Acquisition Deal Connected to Chinese-Backed Semiconductor Firm


Source: ChinaSourcingNews.com ChinaSourcingNews.com

January 3, 2026

China’s biopharma sector ‘in prime position to challenge US leadership’


Source: scmp.com scmp.com

January 1, 2026

Lockheed Martin Secures $328.5 Million Military Deal with Taiwan Amid Rising Tensions


Source: devdiscourse.com devdiscourse.com

November 15, 2025

Trump Secures New Trade Deal Frameworks in Europe and Latin America


Source: foreignpolicy.com foreignpolicy.com

October 6, 2025

Thunderstone Acquisition Corp. Seeks $50 Million in IPO


Source: ChinaMoneyNetwork.com ChinaMoneyNetwork.com